Trevi Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0M | 2.2M | 1.34 |
| 2023-09-30 | $4.3M | 2.0M | 2.18 |
| 2023-06-30 | $4.6M | 1.9M | 2.39 |
| 2023-03-31 | $2.8M | 1.5M | 1.85 |
| 2022-12-31 | $2.8M | 1.4M | 1.93 |
| 2022-06-30 | $666k | 237k | 2.81 |
| 2022-03-31 | $337k | 153k | 2.20 |
| 2021-09-30 | $192k | 137k | 1.40 |
| 2021-06-30 | $300k | 133k | 2.25 |
| 2021-03-31 | $361k | 133k | 2.71 |
| 2020-12-31 | $322k | 133k | 2.42 |
| 2020-09-30 | $537k | 133k | 4.03 |
| 2020-06-30 | $914k | 139k | 6.58 |
| 2020-03-31 | $495k | 150k | 3.29 |
| 2019-12-31 | $564k | 150k | 3.75 |
| 2019-09-30 | $677k | 150k | 4.50 |